# US 2025/0082839 A1 · Fluid therapy based on sodium excretion, and associated systems, devices, and methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082839 A1
- Document ID: US20250082839A1
- Status: Published application
- Kind: A1
- Application number: 18/883,857
- Filed: 2024-09-12
- Published: 2025-03-13
- Earliest claimed: 2023-09-12
- Assignees: Reprieve Cardiovascular, Inc.
- Applicants: Reprieve Cardiovascular, Inc.
- Inventors: Andrew V. Halpert; Antony Jonathan Fields; Jeffrey Testani
- Web page: https://patentgrep.com/patent/US20250082839A1

## CPC

- A61B 5/4839: {combined with drug delivery}
- A61B 5/201: {Assessing renal or kidney functions}
- A61B 5/208: {adapted to determine urine quantity, e.g. flow, volume}
- A61M 5/1407: {Infusion of two or more substances}
- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

This present disclosure relates to fluid therapy based on sodium excretion, and associated systems, devices, and methods. Exemplary methods can include receiving a sodium excretion input for the patient; receiving a urine output rate; determining an adjusted urine output rate based on the sodium excretion input and the urine output rate; and providing fluid therapy based on the adjusted urine output rate. By determining the amount and/or rate of the infused diuretic and/or hydration fluid based on a patient's actual sodium excretion levels, embodiments of the present technology can optimize and/or customize all or a subset of a diuretic therapy to an individual patient's physiology.

## Claims

### Claim 1

A fluid therapy system, comprising:
a diuretic source configured to provide a diuretic to a patient;
a hydration fluid source configured to provide a hydration fluid to the patient; and
a controller, wherein the controller is configured to—obtain a sodium excretion input for the patient;
determine a sodium output rate based at least in part on the sodium excretion input; and
based on the sodium output rate, (i) cause the diuretic to be administered to the patient at one or more diuretic dosage rates and (ii) cause the hydration fluid to be administered to the patient at one or more hydration rates to produce a net fluid loss in the patient.

### Claim 2 (depends on 1)

The fluid therapy system of claim 1, further comprising a urine measurement device configured to measure urine output of the patient, wherein the controller is further configured to determine the sodium output rate based at least in part on the sodium excretion input and a urine output rate obtained via the urine measurement device.

### Claim 3 (depends on 1)

The fluid therapy system of claim 1, wherein the controller is further configured to:
compare the sodium excretion input with one or more sodium output rate thresholds associated with the administration of the hydration fluid and/or the diuretic to the patient; and
cause the diuretic and/or the hydration fluid to be administered and/or cause an adjustment to the administration of the diuretic and/or the hydration fluid based at least in part on the comparison.

### Claim 4 (depends on 1)

The fluid therapy system of claim 1, wherein the sodium excretion input includes a conductivity of the patient's urine.

### Claim 5 (depends on 1)

The fluid therapy system of claim 1, wherein the sodium excretion input includes a concentration of sodium in the patient's urine.

### Claim 6 (depends on 1)

The fluid therapy system of claim 1, wherein:
before receiving the sodium excretion input, the controller is configured to provide the hydration fluid at a hydration fluid infusion rate; and
after receiving the sodium excretion input, the controller is configured to adjust the hydration fluid infusion rate based on the sodium output rate.

### Claim 7 (depends on 1)

The fluid therapy system of claim 1, wherein:
before receiving the sodium excretion input, the controller is configured to provide the diuretic at a diuretic dosage rate; and
after receiving the sodium excretion input, the controller is configured to adjust the diuretic dosage rate based on the sodium output rate.

### Claim 8 (depends on 1)

The fluid therapy system of claim 1, further comprising a user interface, wherein the controller is configured to obtain the sodium excretion input for the patient from a user input via the user interface.

### Claim 9 (depends on 1)

The fluid therapy system of claim 1, further comprising a sensor configured to detect a sodium concentration in urine output from the patient, wherein the controller is configured to obtain the sodium excretion input for the patient based at least in part on the sodium concentration detected via the sensor.

### Claim 10 (depends on 1)

The fluid therapy system of claim 1, wherein, during a first time period, the controller is configured to provide fluid therapy based on an assumed sodium excretion input and, during a second time period after the first time period, the controller is configured to obtain the sodium excretion input for the patient.

### Claim 11 (depends on 10)

The fluid therapy system of claim 10, wherein the assumed sodium excretion input is an assumed sodium excretion based at least in part on a measured urine output rate for the patient and an assumed concentration of sodium in the patient's urine.

### Claim 12 (depends on 11)

The fluid therapy system of claim 11, wherein the assumed concentration of sodium is 140 mmol/L.

### Claim 13 (depends on 1)

The fluid therapy system of claim 1, wherein the controller is configured to obtain a sodium loss based on the sodium output rate and cause an amount the hydration fluid to be administered to replace a percentage of the sodium loss.

### Claim 14 (depends on 13)

The fluid therapy system of claim 13, wherein the percentage is up to 50% of the sodium loss.

### Claim 15

A method for providing fluid therapy to a patient, the method comprising:
obtaining a sodium excretion input for the patient;
determining a sodium output rate based at least in part on the sodium excretion input; and
based on the sodium output rate, (i) causing a diuretic to be administered to the patient at one or more diuretic dosage rates and (ii) causing a hydration fluid to be administered to the patient at one or more hydration rates to produce a net fluid loss in the patient.

### Claim 16 (depends on 15)

The method of claim 15, further comprising obtaining a urine output rate for the patient, wherein determining the sodium output rate includes determining the sodium output rate based at least in part on the sodium excretion input and the urine output rate.

### Claim 17 (depends on 15)

The method of claim 15, wherein determining the sodium excretion input includes determining a conductivity of the patient's urine.

### Claim 18 (depends on 15)

The method of claim 15, wherein obtaining the sodium excretion input includes obtaining a concentration of sodium in the patient's urine.

### Claim 19 (depends on 15)

The method of claim 15, wherein obtaining the sodium excretion input includes obtaining the sodium excretion input from a user via a user interface.

### Claim 20 (depends on 15)

The method of claim 15, wherein obtaining the sodium excretion input incudes obtaining the sodium excretion input via a sensor configured to detect a level of sodium in the patient's urine.

### Claim 21 (depends on 15)

The method of claim 15, wherein obtaining the sodium excretion input includes:
collecting urine within a collection container of a fluid therapy system;
removing a urine sample from the urine collected within the collection container;
measuring a concentration of sodium in the urine sample; and
causing a processor of the fluid therapy system to obtain the concentration.

### Claim 22 (depends on 21)

The method of claim 21 wherein causing the processor to obtain the concentration includes inputting the concentration via a user interface of the fluid therapy system.

### Claim 23 (depends on 15)

The method of claim 15, wherein, during a first time period, the method comprises causing the hydration fluid and/or the diuretic to be administered at one or more first rates that are based at least in part on an assumed sodium excretion input and, during a second time period after the first time period, the method comprises causing the hydration fluid and/or the diuretic to be administered at one or more second rates that are based at least in part on the obtained sodium excretion input for the patient.

### Claim 24 (depends on 23)

The method of claim 23, wherein the assumed sodium excretion input is an assumed sodium excretion based at least in part on an obtained urine output rate for the patient and an assumed concentration of sodium in the patient's urine.

### Claim 25 (depends on 23)

The method of claim 23 wherein the first time period is up to 6 hours.

### Claim 26 (depends on 23)

The method of claim 23 wherein the first time period includes an amount of time before the patient has output a predetermined quantity of urine.

### Claim 27 (depends on 23)

The method of claim 23 wherein the first time period includes an amount of time before the patient has output at least 1 liter of urine.

### Claim 28 (depends on 15)

The method of claim 15 wherein (i) causing the diuretic to be administered to the patient at the one or more diuretic dosage rates and/or (ii) causing the hydration fluid to be administered to the patient at the one or more hydration rates includes causing the diuretic and/or the hydration fluid to be administered to produce a net sodium loss in the patient.

### Claim 29 (depends on 15)

The method of claim 15 wherein causing the hydration fluid to be administered includes replacing a percentage of the sodium lost from the patient via urine during fluid therapy.

### Claim 30 (depends on 29)

The method of claim 29, wherein the percentage is up to 50% of the sodium lost from the patient via urine during fluid therapy.
